The [FURL=https://www.industryarc.com/Report/16778/clinical-trial-imaging-market.html?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]Clinical Trial Imaging market[/FURL] size is estimated to reach $841 million by 2026, growing at a CAGR of 7.1% during the forecast period 2021-2026. Clinical Trial Imaging involves the use of imaging modalities, analysis services, and software to effectively determine the efficacy of novel medications before commercial release. Clinical Imaging techniques are increasingly used in oncology drug clinical trials to provide evidence for the drug’s effectiveness and safety. The imaging systems commonly used in clinical trials include Positron Emission Tomography (PET), Optical Coherence Tomography (OCT), Magnetic Resonance Imaging (MRI), and Ultrasound.Key Takeaways
Geographically, the North American Clinical Trial Imaging market accounted for the largest share in 2020 owing to an increase in the number of CROs and the presence of key Biotechnology, Pharmaceutical, and Medical Device manufacturing companies in the region.
An increase in technological advancements in both imaging systems and drug development processes is anticipated to drive the market. However, the high cost of imaging modalities is projected to challenge demand generation.
Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Clinical Trial Imaging Report.
Download Sample Report @ [FURL]www.industryarc.com/pdfdownload.php?id=16778[/FURL]
Clinical Trial Imaging Market Segment Analysis-By Geography
The Clinical Trial Imaging Market based on Geography can be segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. The North American segment is projected to dominate the Clinical Trial Imaging market during the forecast period 2021-2026 with a market share of 34% owing to the presence of highly developed healthcare infrastructure, large public and private investment in research and development, and rising cases of chronic illnesses such as cancer and cardiovascular diseases in the region. Moreover, the presence of major biotechnology, pharmaceutical, and medical device manufacturing companies in the region such as Pfizer, Moderna, Johnson and Johnson, General Electric, Medtronic
Clinical Trial Imaging Market Drivers
Increase in Cancer Cases is Projected to Drive Market Growth
The rise in Research and Development Expenditure is Anticipated to Boost Demand
Clinical Trial Imaging Market Industry Outlook:
The top 10 companies of the industry include Bioclinica Inc, Paraxel International Corporation, Biomedical Systems Corporation, Biotechnology Inc., Cardiovascular Imaging Technologies LLC, IXICO PLC, Radiant Sage LLC, Worldcare Clinical LLC, Intrinsic Imaging, ICON PLC.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.